X4 Pharmaceuticals, Inc. Gains 81.69%

X4 Pharmaceuticals, Inc. (XFOR:NASDAQ) rocketted at $2.58, a gain of 81.7%. On Tue, Aug 12, 2025, XFOR:NASDAQ hit a New 2-Week High of $2.58. The stock appeared on our News Catalysts scanner on Mon, Aug 11, 2025 at 08:51 AM in the 'EARNINGS' category. From Tue, Jul 29, 2025, the stock recorded 30.00% Up Days and 27.27% Green Days

About X4 Pharmaceuticals, Inc. (XFOR:NASDAQ)

Arsanis Inc discovers and develops monoclonal antibodies for the targeted immunotherapy of serious infections. The company's monoclonal antibodies selectively focus on specific pathogens and pathogenic processes which address critical infections while minimizing the collateral damage from antimicrobial overuse, resistance, and microbiome disruption. Few of its products candidates are ASN100, for prevention of pneumonia in high risk, mechanically ventilated patients; ASN500, for prevention of respiratory Syncytial virus; ASN300 and ASN200, for prevention and treatment of bacterial infections.